All Stories

  1. Supraspinatus Muscle Regeneration Following Rotator Cuff Tear: A Study of the Biomarkers Pax7, MyoD, and Myogenin
  2. Stem cell treatment for regeneration of the rotator cuff: study protocol for a prospective single-center randomized controlled trial (Lipo-cuff)
  3. A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication
  4. High-intensity resistance training improves quality of life, muscle endurance and strength in patients with myositis: a randomised controlled trial
  5. Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation
  6. Quality of life in patients with myositis is associated with functional capacity, body composition, and disease activity—Baseline data from a randomized controlled trial
  7. Short term treatment of secondary lymphedema with hyaluronidase injections reduces mouse hindlimb lymphedema
  8. Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment
  9. Response to: Endoscopic Injections of Botulinum Toxin Type A in the Piglet Esophagus Is Safe and Feasible but Did Not Result in any Significant Structural Changes 3 Days after Injection
  10. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
  11. Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine
  12. Stone heart syndrome after prolonged cardioplegia induced cardiac arrest in open-heart surgery – a pilot study on pigs
  13. Reply to “Post‐COVID myopathy”
  14. Early-stage inflammation changes in supraspinatus muscle after rotator cuff tear
  15. Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology
  16. Endoscopic Injections of Botulinum Toxin Type A in the Piglet Esophagus Is Safe and Feasible but Did Not Result in any Significant Structural Changes 3 Days after Injection
  17. Lack of muscle stem cell proliferation and myocellular hypertrophy in sIBM patients following blood-flow restricted resistance training
  18. A mixed pattern of osteolytic and sclerotic lesions is characteristic in metastatic breast cancer patients as evidenced by histomorphometry
  19. Efficacy of bioreactor‐activated bone substitute with bone marrow nuclear cells on fusion rate and fusion mass microarchitecture in sheep
  20. Efficacy of marine bioactive compound fucoidan for bone regeneration and implant fixation in sheep
  21. Validation of a new rat model of urethral sphincter injury and leak point pressure measurements
  22. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting
  23. Oxaliplatin Neuropathy: Predictive Values of Skin Biopsy, QST and Berve Conduction
  24. High-intensity strength training in patients with idiopathic inflammatory myopathies: a randomised controlled trial protocol
  25. The inflammatory response of the supraspinatus muscle in rotator cuff tear conditions
  26. Fibrocytes in early and long-standing rheumatoid arthritis: a 6-month trial with repeated synovial biopsy, imaging and lung function test
  27. The Effect of Botulinum Toxin Type A Injections on Stricture Formation, Leakage Rates, Esophageal Elongation, and Anastomotic Healing Following Primary Anastomosis in a Long- and Short-Gap Esophageal Atresia Model – A Protocol for a Randomized, Control...
  28. Recessive Inheritance of a Rare Variant in the Nuclear Mitochondrial Gene for AARS2 in Late-Onset Dilated Cardiomyopathy
  29. Supraspinatus and deltoid muscle fiber composition in rotator cuff tear conditions
  30. C57BL/6J substrain differences in response to high-fat diet intervention
  31. The Cytotoxicity of Metal Nanoparticles Depends on Their Synergistic Interactions
  32. Comparison between stromal vascular fraction and adipose derived stem cells in a mouse lymphedema model
  33. Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke
  34. Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration
  35. Intramural Injection of Botulinum Toxin A in Surgical Treatment of a Long Gap Esophageal Atresia—Rat Model
  36. The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training
  37. Supraspinatus Muscle Fiber Composition in Rotator Cuff Tear Condition
  38. Statin use and peripheral nerve function—A prospective follow‐up study
  39. Idiopathic inflammatory myopathy
  40. Marker Expression of Interstitial Cells in Human Skeletal Muscle: An Immunohistochemical Study
  41. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy‐induced polyneuropathy symptoms and signs
  42. Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score
  43. FRI0640 COMPARING DISEASE ACTIVITY IN THE WRIST BY REPEAT SYNOVIAL BIOPSIES, RAMRIS MAGNETIC RESONANCE SCORE AND EULAR-OMERACT ULTRASOUND SCORE: A 6-MONTH PROSPECTIVE TRIAL IN EARLY AND LONGSTANDING RHEUMATOID ARTHRITIS
  44. Silver nanoparticle-induced expression of proteins related to oxidative stress and neurodegeneration in an in vitro human blood-brain barrier model
  45. Quantification of Chronic Lymphedema in a Revised Mouse Model
  46. Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
  47. BAG3 myopathy is not always associated with cardiomyopathy
  48. Mice Knocked Out for the Primary Brain Calcification–Associated Gene Slc20a2 Show Unimpaired Prenatal Survival but Retarded Growth and Nodules in the Brain that Grow and Calcify Over Time
  49. CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and Mucosa
  50. Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial
  51. The effect of low intensity shockwave treatment (Li-SWT) on human myoblasts and mouse skeletal muscle
  52. Adhesions, infl ammatory response and foreign body giant cells infi ltration of the topical hemostats TachoSil®, Hemopatch™ and Veriset™ – An Animal Study
  53. DOK7 congenital myasthenia may be associated with severe mitral valve insufficiency
  54. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis
  55. SAT0660 Safety, feasibility and tolerability of performing consecutive minimal invasive ultrasound-guided synovial biopsy procedures on the same wrist in a prospective rheumatoid arthritis study
  56. Treatment of Vesicovaginal Fistulas With Autologous Cell Injections—A Randomized Study in an Animal Model
  57. SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo
  58. Effects of scaffold materials on myoblast cell state
  59. Influence of Resistance Training on Neuromuscular Function and Physical Capacity in ALS Patients
  60. Low Oxygen Tension Enhances Expression of Myogenic Genes When Human Myoblasts Are Activated from G0 Arrest
  61. SAT0049 Circulating CD45+ CD34+ CD11B+ Cells Are Immature Fibrocytes and The Level Correlates with The Number of Mononuclear Cells That in Vitro Differentiate To Mature Fibrocytes: A Potential New Marker for Interstitial Lung Disease in Rheumatoid Arth...
  62. Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis
  63. Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65)
  64. A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene
  65. Intramural Injection with Botulinum Toxin Type A in Piglet Esophagus. The Influencer on Maximum Load and Elongation: A Dose Response Study
  66. Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
  67. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands
  68. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy
  69. Neuronal Nitric Oxide Synthase Is Dislocated in Type I Fibers of Myalgic Muscle but Can Recover with Physical Exercise Training
  70. Sympathetic block by metal clips may be a reversible operation
  71. Importance of blood cultures from peripheral veins in pediatric patients with cancer and a central venous line
  72. Duplication in the Microtubule-Actin Cross-linking Factor 1 gene causes a novel neuromuscular condition
  73. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies
  74. Glioma Spheroids Obtained via Ultrasonic Aspiration Are Viable and Express Stem Cell Markers
  75. Hormone replacement therapy increases the risk of cranial meningioma
  76. Prognostic value of Musashi-1 in gliomas
  77. Loss of Function of Slc20a2 Associated with Familial Idiopathic Basal Ganglia Calcification in Humans Causes Brain Calcifications in Mice
  78. Ageing is associated with diminished muscle re‐growth and myogenic precursor cell expansion early after immobility‐induced atrophy in human skeletal muscle
  79. A Novel In Vitro Model for Studying Quiescence and Activation of Primary Isolated Human Myoblasts
  80. Delta-Like 1 Homolog (Dlk1): A Marker for Rhabdomyosarcomas Implicated in Skeletal Muscle Regeneration
  81. Use of statins and risk of glioma: a nationwide case–control study in Denmark
  82. Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy
  83. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects
  84. The importance of being in the right spot
  85. Skeletal muscle glycogen content and particle size of distinct subcellular localizations in the recovery period after a high-level soccer match
  86. Effects of Chemotherapeutics on Organotypic Corticostriatal Slice Cultures Identified by A Panel of Fluorescent and Immunohistochemical Markers
  87. Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8-10, 2011
  88. Quantitative gene expression profiling of CD45+ and CD45− skeletal muscle‐derived side population cells
  89. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies
  90. Human skeletal muscle glycogen utilization in exhaustive exercise: role of subcellular localization and fibre type
  91. Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle
  92. Newly formed skeletal muscle fibers are prone to false positive immunostaining by rabbit antibodies
  93. CD133+ niches and single cells in glioblastoma have different phenotypes
  94. Subcellular localization-dependent decrements in skeletal muscle glycogen and mitochondria content following short-term disuse in young and old men
  95. Abstracts from the 9th Meeting of The European Association of NeuroOncology, September 16-19, 2010, Maastricht, The Netherlands
  96. Parameters in Three-Dimensional Osteospheroids of Telomerized Human Mesenchymal (Stromal) Stem Cells Grown on Osteoconductive Scaffolds That PredictIn VivoBone-Forming Potential
  97. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-β/activin/nodal signaling using SB-431542
  98. Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle
  99. Human skeletal muscle intramyofibrillar glycogen is decreased after 14 days of immobilisation in young and old men
  100. Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
  101. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
  102. An empirical analysis of the precision of estimating the numbers of neurons and glia in human neocortex using a fractionator-design with sub-sampling
  103. Lipid droplets interact with mitochondria using SNAP23
  104. “The preadipocyte factor” DLK1 marks adult mouse adipose tissue residing vascular cells that lack in vitro adipogenic differentiation potential
  105. Distinct effects of subcellular glycogen localization on tetanic relaxation time and endurance in mechanically skinned rat skeletal muscle fibres
  106. Characterization of DLK1+ Cells Emerging During Skeletal Muscle Remodeling in Response to Myositis, Myopathies, and Acute Injury
  107. Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles
  108. Teratoma Formation by Human Embryonic Stem Cells Is Site Dependent and Enhanced by the Presence of Matrigel
  109. A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
  110. Non-cultured adipose-derived CD45− side population cells are enriched for progenitors that give rise to myofibres in vivo
  111. Secreted Protein Acidic and Rich in Cysteine (SPARC) in Human Skeletal Muscle
  112. CD133 identifies perivascular niches in grade II–IV astrocytomas
  113. Immunohistochemical Markers for Quantitative Studies of Neurons and Glia in Human Neocortex
  114. Transgenic Overexpression of ADAM12 Suppresses Muscle Regeneration and Aggravates Dystrophy in Aged mdx Mice
  115. Depletion of vesicular zinc in dorsal horn of spinal cord causes increased neuropathic pain in mice
  116. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans
  117. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene
  118. Transgenic engineering of male-specific muscular hypertrophy
  119. Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells
  120. Ectopic Expression of DLK1 Protein in Skeletal Muscle of Padumnal Heterozygotes Causes the Callipyge Phenotype
  121. Enhanced procollagen processing in skeletal muscle after a single bout of eccentric loading in humans
  122. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise
  123. Adult human mesenchymal stem cell as a target for neoplastic transformation
  124. GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern
  125. Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin
  126. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased  7 integrin, utrophin and associated glycoproteins
  127. Development of acromegaly in patients with prolactinomas
  128. GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?
  129. ADAM12 Alleviates the Skeletal Muscle Pathology in mdx Dystrophic Mice
  130. Regenerating human muscle fibres express GLUT3 protein
  131. GLUT4 expression at the plasma membrane is related to fibre volume in human skeletal muscle fibres
  132. Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk
  133. Fetal Antigen 1 in Healthy Adults and Patients with Pituitary Disease: Relation to Physiological, Pathological, and Pharmacological GH Levels
  134. A cellular model system of differentiated human myotubes
  135. Fetal Antigen 1 in Healthy Adults and Patients with Pituitary Disease: Relation to Physiological, Pathological, and Pharmacological GH Levels
  136. Proliferation conditions for human satellite cells The fractional content of satellite cells
  137. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure
  138. The GLUT4 density in slow fibres is not increased in athletes. How does training increase the GLUT4 pool originating from slow fibres?
  139. Inhibitory zinc-enriched terminals in mouse spinal cord
  140. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes
  141. GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients
  142. Increased Expression of a Novel Early Activation Surface Membrane Receptor in Cutaneous T Cell Lymphoma Cells
  143. Retrograde tracing of zinc-enriched (ZEN) neuronal somata in rat spinal cord
  144. Depletion of Acyl-Coenzyme A-Binding Protein Affects Sphingolipid Synthesis and Causes Vesicle Accumulation and Membrane Defects inSaccharomyces cerevisiae
  145. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non‐functioning pituitary adenomas
  146. Induction of GLUT-1 protein in adult human skeletal muscle fibers
  147. Glucose transporter expression in human skeletal muscle fibers
  148. Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients
  149. Zinc-enriched (ZEN) terminals in mouse spinal cord: immunohistochemistry and autometallography
  150. Zinc-enriched boutons in rat spinal cord
  151. Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle
  152. Simple Numerical Chromosome Aberrations Characterize Pituitary Adenomas
  153. Stereological estimation of nuclear mean volume in invasive meningiomas
  154. Fetal antigen 1 and growth hormone in pituitary somatotroph cells
  155. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study
  156. Congenital intracranial meningioma
  157. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrence-free breast cancer patients
  158. PATHOLOGY OF SKELETAL MUSCLE IN FIBROMYALGIA: A HISTO-IMMUNO-CHEMICAL AND ULTRASTRUCTURAL STUDY
  159. Stereological estimation of nuclear volume in benign and atypical meningiomas
  160. Foetal antigen 2 (FA2) in the stromal reaction induced by breast carcinoma
  161. Symposium 6: Endocrinology
  162. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus
  163. IgD‐λ monoclonal gammaopathy and axonal neuropathy
  164. Peripheral nerve injury causes transient expression of MHC class I antigens in rat motor neurons and skeletal muscles
  165. IgM monoclonal gammopathy and neuropathy in two siblings.
  166. Axotomy induces MHC class I antigen expression on rat nerve cells
  167. HLA‐DR‐expressing cells and T‐lymphocytes in sural nerve biopsies
  168. Relation between bladder filling and anal sphincter reflexes
  169. Immunohistochemical demonstration of glial markers in retinoblastomas
  170. Relation between flexor spasms, uninhibited detrusor contractions and anal sphincter activity.
  171. Catecholamine innervation of the caudal spinal cord in the rat
  172. Somatostatin in the caudal spinal cord: An immunohistochemical study of the spinal centers involved in the innervation of pelvic organs
  173. The role of spinal pathways in dopamine mediated alteration in the tail-flick reflex in rats
  174. Neural connections between antrum and duodenum
  175. Localization of cholecystokininlike immunoreactivity in the rat spinal cord, with particular reference to the autonomic innervation of the pelvic organs
  176. Fiber types in the striated urethral and anal sphincters
  177. Anal sphincter responses after perianal electrical stimulation.
  178. Idiopathic Detrusor Sphincter Dyssynergia in Neurologically Normal Patients with Voiding Abnormalities
  179. Onuf's nucleus X: A morphological study of a human spinal nucleus
  180. Organization of the motoneurons innervating the pelvic muscles of the male rat
  181. Sulfide silver stainability of a type of bouton in spinal cord motoneuron neuropil: An electron microscopic study with Timm's method for demonstration of heavy metals
  182. ANT‐EGG CATARACT
  183. ANT‐EGG CATARACT
  184. Paramembranous densities of ?C? terminalmotoneuron synapses in the spinal cord of the rat
  185. Histochemical demonstration of mercury induced changes in rat neurons
  186. Heavy metals in the spinal cord of normal rats and of animals treated with chelating agents: A quantitative (Zinc, copper, and lead) and histochemical study
  187. POLYSACCHARIDE COATING OF HUMAN CORNEAL ENDOTHELIUM
  188. Sulfide silver architectonics of the rat, cat, and guinea pig spinal cord